Variants of CARD15 are Associated with an Aggressive Clinical Course of Crohn's Disease—An IG-IBD Study

BACKGROUND:Three major variants of the CARD15 gene confer susceptibility to Crohn's disease (CD). Whether or not these variants correlate with specific clinical features of the disease is under evaluation.AIM:We investigated the possible association of CARD15 variants with specific clinical characteristics, including the occurrence of anti-Saccharomyces cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA), in a large cohort of inflammatory bowel disease (IBD) patients and their unaffected relatives.METHODS:Three hundred and sixteen CD patients (156 with positive family history), 408 ulcerative colitis (UC) patients (206 with positive family history), 588 unaffected relatives, and 205 unrelated healthy controls (HC) were studied. Single nucleotide polymorphisms (SNPs) R702W, G908R, and L1007finsC of the CARD15 gene were investigated and correlated to age at diagnosis, gender, family history, localization, extraintestinal manifestations, previous resective surgery, stenosing/fistulizing pattern, ANCA, and ASCA.RESULTS:Compared to HC, the frequencies of all three variants in CD were significantly increased: 8.7%versus 4.1% for R702W (p < 0.006), 7.3%versus 2.7% for G908R (p < 0.002), 9.3%versus 0.7% for L1007finsC (p < 0.00001). At least one risk allele was found in 38.2% (p < 0.0001, compared to HC), 13.7% (NS), and 15.1% of CD, UC, and HC, respectively. The L1007finsC risk allele was also significantly increased in unaffected relatives of familial (9.5%; p < 0.00001), and sporadic CD (9%; p < 0.00001), compared to HC (0.7%). Sixteen healthy relatives, carriers of two risk alleles, were asymptomatic after 5–8 yr of follow-up. CD carriers of at least one variant were younger (p= 0.03), more likely to have ileal localization (p= 0.0001), stenosing pattern (p= 0.01), previous resective surgery (p= 0.0001), and presence of ASCA (p= 0.0001). No difference in SNPs frequency between familial and sporadic cases of CD was found.CONCLUSIONS:In our population, both familial and sporadic CD patients carrying at least one major variant of CARD15 had an aggressive clinical course.

[1]  H. Drummond,et al.  Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations , 2004, Clinical and experimental immunology.

[2]  G. Novelli,et al.  CARD15 Mutation Analysis in an Italian Population: Leu1007fsinsC but Neither Arg702Trp nor Gly908Arg Mutations Are Associated with Crohn’s Disease , 2004, Inflammatory bowel diseases.

[3]  D. Giachino,et al.  Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients , 2004, European Journal of Human Genetics.

[4]  P. Fortina,et al.  The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. , 2004, Gastroenterology.

[5]  A. Andriulli,et al.  Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[7]  S. Dréano,et al.  NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype–phenotype analysis , 2004, European journal of gastroenterology & hepatology.

[8]  E. Rappaport,et al.  Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations , 2003, Journal of Medical Genetics.

[9]  Judy H. Cho,et al.  Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis , 2003, Gut.

[10]  M. Devoto,et al.  CARD15 genotyping in inflammatory bowel disease patients by multiplex pyrosequencing. , 2003, Clinical chemistry.

[11]  Judy H. Cho,et al.  Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use On Crohn's Disease Phenotypes , 2003, Inflammatory bowel diseases.

[12]  H. Zouali,et al.  Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients , 2003, American journal of medical genetics. Part A.

[13]  Changqing Zheng,et al.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. , 2003, World journal of gastroenterology.

[14]  S. Davies,et al.  Crohn's disease and the NOD2 gene: a role for paneth cells. , 2003, Gastroenterology.

[15]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[16]  D. Jewell,et al.  NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population , 2003, Alimentary pharmacology & therapeutics.

[17]  J. Hugot,et al.  Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn’s disease colon , 2003, Gut.

[18]  A. Andriulli,et al.  Genetics of inflammatory bowel disease: the beginning of the end or the end of the beginning? , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  M. Färkkilä,et al.  CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease , 2003, Gut.

[20]  D. Podolsky,et al.  CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.

[21]  P. Rosenstiel,et al.  TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .

[22]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[23]  J. Hugot,et al.  Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. O'Morain,et al.  Association of NOD2 with Crohn's Disease in a homogenous Irish population , 2003, European Journal of Human Genetics.

[25]  E. Kuipers,et al.  CARD15 and Crohn's Disease: Healthy Homozygous Carriers of the 3020insC Frameshift Mutation , 2003, American Journal of Gastroenterology.

[26]  Judy H. Cho,et al.  The genetics of inflammatory bowel disease. , 2003, Gastroenterology.

[27]  O. Dewit,et al.  Serological markers in inflammatory bowel diseases. , 2003, Best practice & research. Clinical gastroenterology.

[28]  E. G. de la Concha,et al.  Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease , 2003, Scandinavian journal of gastroenterology.

[29]  Yasunori Ogura,et al.  Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation* , 2002, The Journal of Biological Chemistry.

[30]  Yusuke Nakamura,et al.  Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease , 2002, Journal of Human Genetics.

[31]  M. Daly,et al.  CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. , 2002, American journal of human genetics.

[32]  T. Hibi,et al.  Lack of common NOD2 variants in Japanese patients with Crohn's disease. , 2002, Gastroenterology.

[33]  C. Folwaczny,et al.  The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. , 2002, Gastroenterology.

[34]  M. Vatn,et al.  Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study , 2002, The Lancet.

[35]  C. O'Morain,et al.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.

[36]  T. Ahmad,et al.  The molecular classification of the clinical manifestations of Crohn's disease. , 2002, Gastroenterology.

[37]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[38]  B. Alizadeh,et al.  CARD15 gene and the classification of Crohn's disease , 2002, Immunogenetics.

[39]  A. Andriulli,et al.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study , 2001, American Journal of Gastroenterology.

[40]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[41]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[42]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[43]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[44]  D. Jewell,et al.  A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.

[45]  B. Alizadeh,et al.  Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[46]  K. Huse,et al.  Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations , 2003, European Journal of Human Genetics.

[47]  S. Targan,et al.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. , 2002, Gastroenterology.

[48]  Philipp J. Brown.  The Beginning of the End or the End of the Beginning , 2002 .